{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:50Z","timestamp":1793126030560,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jconrel.2026.115460","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:05:15Z","timestamp":1792166715000},"page":"115460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy"],"prefix":"10.1016","volume":"400","author":[{"given":"Tianjiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115460_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115460_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202200905","article-title":"Peptide-based cancer vaccine delivery via the STING\u0394TM-cGAMP complex","volume":"11","author":"He","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115460_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0020","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115460_bb0025","series-title":"Metabolomics for Personalized Vaccinology","first-page":"341","article-title":"Chapter 8 - dendritic cell-based cancer vaccine production","author":"Rahman","year":"2024"},{"key":"10.1016\/j.jconrel.2026.115460_bb0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115460_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101324","article-title":"Cancer vaccines: target antigens, vaccine platforms and preclinical models","volume":"101","author":"Ruzzi","year":"2025","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2026.115460_bb0040","article-title":"A universal therapeutic vaccine leveraging autologous pre-existing immunity to eliminate in situ uniformly engineered heterogeneous tumor cells","volume":"37","author":"Wu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115460_bb0045","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1038\/s41467-022-33831-7","article-title":"In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses","volume":"13","author":"Guo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115460_bb0050","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1021\/acsnano.5c16193","article-title":"Probiotic-driven therapeutic vaccine for in vivo reprogramming of tumor cells to elicit postoperative antitumor immunity","volume":"20","author":"Gu","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115460_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2022.09.018","article-title":"A supramolecular self-assembled nanomaterial for synergistic therapy of immunosuppressive tumor","volume":"351","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115460_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2024.09.041","article-title":"Recent advances in AIE-based platforms for cancer immunotherapy","volume":"376","author":"Chen","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115460_bb0065","article-title":"Transformable supramolecular self-assembled peptides for cascade self-enhanced ferroptosis primed cancer immunotherapy","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115460_bb0070","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.bjc.6604059","article-title":"Photodynamic therapy-generated vaccines: relevance of tumour cell death expression","volume":"97","author":"Korbelik","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115460_bb0075","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1087621","article-title":"Phosphatidylserine receptor is required for clearance of apoptotic cells","volume":"302","author":"Li","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115460_bb0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nature03964","article-title":"Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells","volume":"437","author":"Yoshida","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115460_bb0085","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.115460_bb0090","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/cdd.2016.7","article-title":"Exposure of phosphatidylserine on the cell surface","volume":"23","author":"Nagata","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.115460_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10495-008-0187-8","article-title":"Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications","volume":"13","author":"Silva","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.jconrel.2026.115460_bb0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jconrel.2026.115460_bb0105","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-21-4260","article-title":"Thymosin \u03b1-1 reverses M2 polarization of tumor-associated macrophages during efferocytosis","volume":"82","author":"Wei","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115460_bb0110","doi-asserted-by":"crossref","first-page":"31077","DOI":"10.1021\/acsnano.5c09460","article-title":"Reprogramming macrophage via an antigen phagocytosis-presentation nanoenhancer for improved cancer immunotherapy","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115460_bb0115","article-title":"Macrophage-mediated tumor cell phagocytosis: opportunity for nanomedicine intervention","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115460_bb0120","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0125","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415","article-title":"Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis","volume":"84","author":"Koopman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115460_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215857","article-title":"Annexin A5 as a targeting agent for cancer treatment","volume":"547","author":"Woodward","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115460_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14821-z","article-title":"Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment","volume":"11","author":"Kang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115460_bb0140","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.tibs.2017.06.004","article-title":"Phosphatidylserine is the signal for TAM receptors and their ligands","volume":"42","author":"Lemke","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2026.115460_bb0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","article-title":"The distribution and function of phosphatidylserine in cellular membranes","volume":"39","author":"Leventis","year":"2010","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.jconrel.2026.115460_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2017.08.012","article-title":"Phosphatidylserine: a cancer cell targeting biomarker","volume":"52","author":"Sharma","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0155","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/cr.2013.115","article-title":"Mechanisms of apoptotic phosphatidylserine exposure","volume":"23","author":"Mari\u00f1o","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115460_bb0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/cdd.2012.93","article-title":"Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm","volume":"20","author":"Lee","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.115460_bb0165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.1900072","article-title":"Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection","volume":"204","author":"Aaes","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0170","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1021\/acs.bioconjchem.1c00461","article-title":"Bioorthogonal chemistry and its applications","volume":"32","author":"Bird","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.115460_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s43586-021-00028-z","article-title":"Bioorthogonal chemistry","volume":"1","author":"Scinto","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.jconrel.2026.115460_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nchembio.2024","article-title":"Development and application of bond cleavage reactions in bioorthogonal chemistry","volume":"12","author":"Li","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0185","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1002\/anie.202009408","article-title":"Manipulating the click reactivity of dibenzoazacyclooctynes: from azide click component to caged acylation reagent by silver catalysis","volume":"59","author":"Shi","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115460_bb0190","doi-asserted-by":"crossref","first-page":"18089","DOI":"10.1021\/acsnano.3c04884","article-title":"Efferocytosis nanoinhibitors to promote secondary necrosis and potentiate the immunogenicity of conventional cancer therapies for improved therapeutic benefits","volume":"17","author":"Wu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115460_bb0195","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10495-017-1413-z","article-title":"The immune response to secondary necrotic cells","volume":"22","author":"Sachet","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.jconrel.2026.115460_bb0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/15476910903204058","article-title":"AnnexinA5 renders dead tumor cells immunogenic--implications for multimodal cancer therapies","volume":"6","author":"Frey","year":"2009","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0205","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1084\/jem.20040327","article-title":"Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo","volume":"200","author":"Bondanza","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115460_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0215","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.3c11464","article-title":"Dual-responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115460_bb0220","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19970-9","article-title":"Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death","volume":"11","author":"Hayashi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115460_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115460_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and metastasis in cancer: molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115460_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12905-023-02848-5","article-title":"Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study","volume":"24","author":"Xie","year":"2024","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jconrel.2026.115460_bb0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115460_bb0250","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: can we be more clever than cancer cells?","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0255","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-18-3125","article-title":"Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma","volume":"79","author":"Ma","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115460_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115460_bb0265","doi-asserted-by":"crossref","first-page":"17582","DOI":"10.1073\/pnas.1409700111","article-title":"Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation","volume":"111","author":"Hefetz-Sela","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115460_bb0270","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115460_bb0275","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41551-018-0254-6","article-title":"A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer","volume":"2","author":"Kulkarni","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jconrel.2026.115460_bb0280","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cac2.12272","article-title":"Phosphatidylserine released from apoptotic cells in tumor induces M2-like macrophage polarization through the PSR-STAT3-JMJD3 axis","volume":"42","author":"Liang","year":"2022","journal-title":"Cancer Commun. (London, Engl.)"},{"key":"10.1016\/j.jconrel.2026.115460_bb0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115460_bb0295","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0300","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","article-title":"Cancer vaccines: building a bridge over troubled waters","volume":"185","author":"Sellars","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115460_bb0305","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0310","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115460_bb0315","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115460_bb0320","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41590-019-0399-9","article-title":"Adaptation and memory in immune responses","volume":"20","author":"Natoli","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098624","article-title":"Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression","volume":"9","author":"Bailey-Downs","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115460_bb0330","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s44222-024-00196-z","article-title":"Engineering photodynamics for treatment, priming and imaging","volume":"2","author":"Obaid","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.jconrel.2026.115460_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer-expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0340","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115460_bb0345","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41551-020-0599-5","article-title":"Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells","volume":"4","author":"Li","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jconrel.2026.115460_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S134834","article-title":"Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer","volume":"7","author":"Belzile","year":"2018","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jconrel.2026.115460_bb0355","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/417182a","article-title":"Identification of a factor that links apoptotic cells to phagocytes","volume":"417","author":"Hanayama","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115460_bb0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115460_bb0365","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0163-7827(03)00025-0","article-title":"Exposure of platelet membrane phosphatidylserine regulates blood coagulation","volume":"42","author":"Lentz","year":"2003","journal-title":"Prog. Lipid Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:51:20Z","timestamp":1793123480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":73,"alternative-id":["S0168365926008643"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115460","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115460"}}